FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

André Schrauder

Research Profile

Disorders

Concepts & Ideas

Physiology

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
R Beier; Arndt Borkhardt; U Creutzig; Karoline Ehlert; Matthias Eyrich; Johann Greil; Bernd Gruhn; Rupert Handgretinger; W Holter; Thomas Klingebiel; Bernhard Kremens; Peter Lang; C Mauz-Körholz; R Meisel; I Müller; Christina Peters; Dirk Reinhardt; André Schrauder; Ansgar Schulz; F R Schuster; Petr Sedlacek; Brigitte Strahm; Karl-Walter Sykora; Wilhelm Wössmann; Martin Zimmermann; Michael H Albert; Peter Bader; M G Sauer
Allo-SCT using BU, CY and melphalan for children with AML in second CR.
Petra Dörge; Jochen Harbott; Rolf Koehler; Wolf-Dieter Ludwig; Barbara Meissner; Anja Möricke; Richard Ratei; Denis Schewe; Martin Schrappe; André Schrauder; Martin Stanulla; Andrea Teigler-Schlegel; Martin Zimmermann; Claus R Bartram; Jean-Pierre Bouquin; Gunnar Cario
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Giuseppe Gaipa; Leonid Karawajew; Wolf-Dieter Ludwig; Oscar Maglia; Renate Panzer-Grümayer; Richard Ratei; Simona Sala; Martin Schrappe; André Schrauder; Angela Schumich; Daniela Silvestri; Maria Grazia Valsecchi; Marinella Veltroni; Tiziana Villa; Alessandra Benetello; Andrea Biondi; Barbara Buldini; Giovanni Cazzaniga; Valentino Conter; Michael Dworzak; Giuseppe Basso
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of André Schrauder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: R Beier; Arndt Borkhardt; U Creutzig; Karoline Ehlert; Matthias Eyrich; Johann Greil; Bernd Gruhn; Rupert Handgretinger; W Holter; Thomas Klingebiel; Bernhard Kremens; Peter Lang; C Mauz-Körholz; R Meisel; I Müller; Christina Peters; Dirk Reinhardt; André Schrauder; Ansgar Schulz; F R Schuster; Petr Sedlacek; Brigitte Strahm; Karl-Walter Sykora; Wilhelm Wössmann; Martin Zimmermann; Michael H Albert; Peter Bader; M G Sauer
Allo-SCT using BU, CY and melphalan for children with AML in second CR.
Bone marrow transplantation 2013;48(5):651-6.
2013: Petra Dörge; Jochen Harbott; Rolf Koehler; Wolf-Dieter Ludwig; Barbara Meissner; Anja Möricke; Richard Ratei; Denis Schewe; Martin Schrappe; André Schrauder; Martin Stanulla; Andrea Teigler-Schlegel; Martin Zimmermann; Claus R Bartram; Jean-Pierre Bouquin; Gunnar Cario
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Haematologica 2013;98(3):428-32.
2012: Giuseppe Gaipa; Leonid Karawajew; Wolf-Dieter Ludwig; Oscar Maglia; Renate Panzer-Grümayer; Richard Ratei; Simona Sala; Martin Schrappe; André Schrauder; Angela Schumich; Daniela Silvestri; Maria Grazia Valsecchi; Marinella Veltroni; Tiziana Villa; Alessandra Benetello; Andrea Biondi; Barbara Buldini; Giovanni Cazzaniga; Valentino Conter; Michael Dworzak; Giuseppe Basso
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.
Haematologica 2012;97(10):1582-93.
2012: Lutz Zeidler; Martin Zimmermann; Andrea Teigler-Schlegel; Christoph Tschan; Karl Welte; Dorothee Bartels; Claus R Bartram; Gunnar Cario; Lilia Goudeva; Sarah Jäger; Rolf Koehler; Wolf-Dieter Ludwig; Barbara Meissner; Anja Möricke; Richard Ratei; Hansjörg Riehm; Martin Schrappe; André Schrauder; Julia Skokowa; Martin Stanulla
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome.
Haematologica 2012;97(3):402-9.
2011: Ursula Creutzig; Michael N Dworzak; Gudrun Fleischhack; Joerg Ritter; Annette Sander; André Schrauder; Jan Starý; Christine von Neuhoff; Arend von Stackelberg; Martin Zimmermann; Jean-Pierre Bourquin; Dirk Reinhardt
CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004.
Pediatric blood & cancer 2011;57(6):986-92.
2011: Ursula Creutzig; Michael Dworzak; Jean-Pierre Bourquin; Selim Corbacioglu; Annette Sander; André Schrauder; Jan Stary; Andrea Teigler-Schlegel; Christine von Neuhoff; Martin Zimmermann; Dirk Reinhardt
Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16).
Blood 2011;118(20):5409-15.
2011: Martin Schrappe; André Schrauder; Maria Grazia Valsecchi; Jacques J M van Dongen; Karl Welte; Martin Zimmermann; Maurizio Aricò; Claus R Bartram; Giuseppe Basso; Andrea Biondi; Barbara Buldini; Giovanni Cazzaniga; Michael Dworzak; Helmut Gadner; Thomas Klingebiel; Rolf Koehler; Franco Locatelli; Chiara Messina; Anja Möricke; Renate Panzer-Grümayer; Rosanna Parasole; Richard Ratei; Alfred Reiter; Beat W Schäfer; Valentino Conter
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.
Blood 2011;118(8):2077-84.
2011: Maike Schmitz; Martin Schrappe; André Schrauder; Martin Stanulla; Joelle Tchinda; Petra Breithaupt; Gunnar Cario; Barbara Meissner; Paulina Mirkowska; Felix K Niggli; Nastassja Scheidegger; Laura Bonapace; Beat Bornhauser; Jean-Pierre Bourquin
Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment.
Blood 2011;118(7):1854-64.
2011: Cornelia Eckert; T Flohr; N Hagedorn; Günter Henze; Renate Kirschner-Schwabe; R Koehler; A Moericke; Martin Schrappe; Claus R Bartram; G Cario; Av Stackelberg; Martin Stanulla; André Schrauder
Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment.
Leukemia 2011;25(8):1305-13.
2011: Hermann Kreyenberg; Christine Mauz-Koerholz; Claudia Rossig; Paul G Schlegel; André Schrauder; Blanca Schuster; Daniel Stachel; Brigitte Strahm; Andre Willasch; Christina Bayer; James F Beck; Stefan Burdach; Tje Lin Chung; Monika Führer; Bernd Gruhn; Ernst Holler; Andrea Jarisch; Hartmut Kabisch; Thomas Klingebiel; Bernhard Kremens; Peter Bader
NOD2/CARD15 gene polymorphisms affect outcome in pediatric allogeneic stem cell transplantation.
Blood 2011;118(4):1181-4.
2011: Tomasz Szczepanski; V H J van der Velden; Esmé Waanders; Roland P Kuiper; Pieter Van Vlierberghe; Bernd Gruhn; Cornelia Eckert; Renate Panzer-Grümayer; Giuseppe Basso; Hélène Cavé; Udo Zur Stadt; Dario Campana; André Schrauder; Rosemary Sutton; Elisabeth R van Wering; Jules P P Meijerink; Jacques J M van Dongen
Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(12):1643-9.
2011: Arend von Stackelberg; Enrico Völzke; Jörn-Sven Kühl; Karl Seeger; André Schrauder; Gabriele Escherich; Günter Henze; Gesche Tallen
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.
European journal of cancer (Oxford, England : 1990) 2011;47(1):90-7.
2010: Gunnar Cario; Martin Zimmermann; Renja Romey; Stefan Gesk; Inga Vater; Jochen Harbott; André Schrauder; Anja Moericke; Shai Izraeli; Takashi Akasaka; Martin J S Dyer; Reiner Siebert; Martin Schrappe; Martin Stanulla
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol.
Blood 2010;115(26):5393-7.
2010: Anja Möricke; Martin Zimmermann; Alfred Reiter; Günter Henze; André Schrauder; Helmut Gadner; Wolf-Dieter Ludwig; J Ritter; Jochen Harbott; Georg Mann; Thomas Klingebiel; Felix Zintl; C Niemeyer; Bernhard Kremens; Felix Niggli; Dietrich Niethammer; Karl Welte; Martin Stanulla; E Odenwald; Hansjörg Riehm; Martin Schrappe
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.
Leukemia 2010;24(2):265-84.
2009: Arne Kristian Schwarz; Martin Stanulla; Gunnar Cario; Thomas Flohr; Rosemary Sutton; Anja Möricke; Philippe Anker; Maurice Stroun; Karl Welte; Claus R Bartram; Martin Schrappe; André Schrauder
Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
Annals of hematology 2009;88(9):897-905.
2009: Martin Stanulla; Elke Schaeffeler; Anja Möricke; Sally A Coulthard; Gunnar Cario; André Schrauder; Peter Kaatsch; Michael Dördelmann; Karl Welte; Martin Zimmermann; Alfred Reiter; Michel Eichelbaum; Hansjörg Riehm; Martin Schrappe; Matthias Schwab
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
Blood 2009;114(7):1314-8.
2009: Martin Stanulla; André Schrauder
Bridging the gap between the north and south of the world: the case of treatment response in childhood acute lymphoblastic leukemia.
Haematologica 2009;94(6):748-52.
2009: V H J van der Velden; L Corral; Maria Grazia Valsecchi; M W J C Jansen; Paola de Lorenzo; Giovanni Cazzaniga; E Renate Panzer-Grümayer; Martin Schrappe; André Schrauder; Claus Meyer; Rolf Marschalek; L L Nigro; M Metzler; G Basso; G Mann; Monique L den Boer; A Biondi; Rob Pieters; J J M Van Dongen
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.
Leukemia 2009;23(6):1073-9.
2009: André Schrauder; S Saleh; Karl-Walter Sykora; H Hoy; Karl Welte; Joachim Boos; Georg Hempel; Lorenz Grigull
Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
Pediatric transplantation 2009;13(4):444-50.
2008: Gunnar Cario; Andrea Fetz; Christian Bretscher; Anja Möricke; André Schrauder; Martin Stanulla; Martin Schrappe
Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
Annals of hematology 2008;87(9):709-16.
2008: Christoph le Viseur; Marc Hotfilder; Simon Bomken; Kerrie Wilson; Silja Röttgers; André Schrauder; Annegret Rosemann; Julie Irving; Ronald W Stam; Leonard D Shultz; Jochen Harbott; Heribert Jürgens; Martin Schrappe; Rob Pieters; Josef Vormoor
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
Cancer cell 2008;14(1):47-58.
2008: André Schrauder; A von Stackelberg; Martin Schrappe; J Cornish; Christina Peters
Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials.
Bone marrow transplantation 2008;41 Suppl 2():S71-4.
2008: Adriana Balduzzi; Paola de Lorenzo; André Schrauder; Valentino Conter; Cornelio Uderzo; Christina Peters; Thomas Klingebiel; Jan Stary; Maria S Felice; Edina Magyarosy; Martin Schrappe; Giorgio Dini; Helmut Gadner; Maria Grazia Valsecchi
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
Haematologica 2008;93(6):925-9.
2008: T Flohr; André Schrauder; Giovanni Cazzaniga; R Panzer-Grümayer; V van der Velden; S Fischer; Martin Stanulla; G Basso; Felix Niggli; Beat W Schäfer; R Sutton; R Koehler; Martin Zimmermann; M G Valsecchi; Helmut Gadner; G Masera; Martin Schrappe; J J M van Dongen; A Biondi; C R Bartram
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.
Leukemia 2008;22(4):771-82.
2007: Nikola Hagedorn; Cécile Acquaviva; Eva Fronkova; Arend von Stackelberg; Andrea Barth; Udo zur Stadt; André Schrauder; Jan Trka; Nathalie Gaspar; Karl Seeger; Günter Henze; Hélène Cavé; Cornelia Eckert
Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of "isolated" and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group.
Blood 2007;110(12):4022-9.
2007: Barbara Meissner; Arndt Borkhardt; Dagmar Dilloo; D Fuchs; W Friedrich; R Handgretinger; Christina Peters; André Schrauder; F R Schuster; Josef Vormoor; Britta Maecker; Karl-Walter Sykora; Felix Zintl; Karl Welte; M Sauer
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia.
Bone marrow transplantation 2007;40(10):945-9.
2007: Gunnar Cario; Shai Izraeli; Anja Teichert; Peter Rhein; Julia Skokowa; Anja Möricke; Martin Zimmermann; André Schrauder; Leonid Karawajew; Wolf-Dieter Ludwig; Karl Welte; Holger J Schünemann; Brigitte Schlegelberger; Martin Schrappe; Martin Stanulla
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4813-20.
2007: Martin Stanulla; Gunnar Cario; Barbara Meissner; André Schrauder; Anja Möricke; Hansjörg Riehm; Martin Schrappe
Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.
Blood cells, molecules & diseases 2007;39(2):160-3.
2007: Jan Zuna; Hélène Cavé; Cornelia Eckert; Tomasz Szczepanski; Claus Meyer; Ester Mejstrikova; Eva Fronkova; Katerina Muzikova; E Clappier; D Mendelova; Patrick Boutard; André Schrauder; J Sterba; Rolf Marschalek; Jacques J M van Dongen; Ondrej Hrusak; Jan Stary; Jan Trka
Childhood secondary ALL after ALL treatment.
Leukemia 2007;21(7):1431-5.
2007: André Schrauder; Cornelia Henke-Gendo; Kathrin Seidemann; Michael Sasse; Gunnar Cario; Anja Moericke; Martin Schrappe; Albert Heim; Armin Wessel
Varicella vaccination in a child with acute lymphoblastic leukaemia.
Lancet 2007;369(9568):1232.
2007: V H J van der Velden; E Renate Panzer-Grümayer; Giovanni Cazzaniga; T Flohr; R Sutton; André Schrauder; G Basso; Martin Schrappe; JM Wijkhuijs; M Konrad; C R Bartram; Guiseppe Masera; A Biondi; Jacques J M van Dongen
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting.
Leukemia 2007;21(4):706-13.
2007: G Mann; Giovanni Cazzaniga; V H J van der Velden; T Flohr; E Csinady; M Paganin; André Schrauder; Alexander Michael Dohnal; M Schrappe; A Biondi; Helmut Gadner; J J M van Dongen; E Renate Panzer-Grümayer
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?
Leukemia 2007;21(4):642-6.
2007: V H J van der Velden; Giovanni Cazzaniga; André Schrauder; J Hancock; Peter Bader; E R Panzer-Grumayer; T Flohr; R Sutton; H Cave; H O Madsen; Jean-Michel Cayuela; Jan Trka; Cornelia Eckert; Letizia Foroni; Udo zur Stadt; Kheira Beldjord; Thorsten Raff; C. Ellen van der Schoot; Jacques J M van Dongen
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.
Leukemia 2007;21(4):604-11.
2007: M W J C Jansen; L Corral; V H J van der Velden; R Panzer-Grümayer; Martin Schrappe; André Schrauder; Rolf Marschalek; Claus Meyer; Monique L den Boer; W J C Hop; Maria Grazia Valsecchi; G Basso; A Biondi; Rob Pieters; Jacques J M van Dongen
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.
Leukemia 2007;21(4):633-41.
2006: André Schrauder; Alfred Reiter; Helmut Gadner; Dietrich Niethammer; Thomas Klingebiel; Bernhard Kremens; Christina Peters; Wolfram Ebell; Martin Zimmermann; Felix Niggli; Wolf-Dieter Ludwig; Hansjörg Riehm; Karl Welte; Martin Schrappe
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5742-9.
2006: J Neudenberger; Marc Hotfilder; Annegret Rosemann; Claudia Langebrake; Dirk Reinhardt; Rob Pieters; André Schrauder; Martin Schrappe; Silja Röttgers; Jochen Harbott; Josef Vormoor
Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
British journal of haematology 2006;133(3):337-44.
2006: Melchior Lauten; André Schrauder; Christian Kardinal; Jochen Harbott; Karl Welte; Brigitte Schlegelberger; Martin Schrappe; Nils von neuhoff
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
Leukemia 2006;20(5):820-6.
2006: Britta Maecker; D Mougiakakos; Martin Zimmermann; M Behrens; S Hollander; André Schrauder; Martin Schrappe; Karl Welte; Christoph Klein
Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients.
Leukemia 2006;20(4):645-9.
2006: Alexander Claviez; Cornelia Eckert; Karl Seeger; André Schrauder; Martin Schrappe; Günter Henze; Arend von Stackelberg
Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.
Haematologica 2006;91(2):272-3.
2005: E Renate Panzer-Grümayer; Giovanni Cazzaniga; V H J van der Velden; Laura del Giudice; Martina Peham; Georg Mann; Cornelia Eckert; André Schrauder; Giuseppe Germano; Jochen Harbott; Giuseppe Basso; Andrea Biondi; Jacques J M van Dongen; Helmut Gadner; Oskar A Haas
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7720-7.
2005: Dirk Reinhardt; Sylke Diekamp; Claudia Langebrake; J Ritter; Jan Stary; Michael Dworzak; André Schrauder; Martin Zimmermann; Gudrun Fleischhack; W-D Ludwig; Jochen Harbott; Ursula Creutzig
Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
Leukemia 2005;19(8):1495-6.
2005: Oliver Teuffel; André Schrauder; Karl-Walter Sykora; M Zimmermann; A Reiter; Karl Welte; Martin Schrappe
The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
Bone marrow transplantation 2005;36(2):145-50.
2005: Martin Stanulla; Elke Schaeffeler; Thomas Flohr; Gunnar Cario; André Schrauder; Martin Zimmermann; Karl Welte; Wolf-Dieter Ludwig; Claus R Bartram; Uli Zanger; Michel Eichelbaum; Martin Schrappe; Matthias Schwab
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
JAMA : the journal of the American Medical Association 2005;293(12):1485-9.
2005: C Peters; André Schrauder; M Schrappe; Arend von Stackelberg; Jan Stary; I Yaniv; H Gadner; T Klingebiel
Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts.
Bone marrow transplantation 2005;35 Suppl 1():S9-11.
2005: Marc Hotfilder; Silja Röttgers; Annegret Rosemann; André Schrauder; Martin Schrappe; Rob Pieters; Heribert Jürgens; Jochen Harbott; Josef Vormoor
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Cancer research 2005;65(4):1442-9.
2005: Gunnar Cario; Martin Stanulla; Bernard M Fine; Oliver Teuffel; Nils von neuhoff; André Schrauder; Thomas Flohr; Beat W Schäfer; Claus R Bartram; Karl Welte; Brigitte Schlegelberger; Martin Schrappe
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia.
Blood 2005;105(2):821-6.
2005: Martin Stanulla; Elke Schäffeler; Stefan Arens; Anke Rathmann; André Schrauder; Karl Welte; Michel Eichelbaum; Uli Zanger; Martin Schrappe; Matthias Schwab
GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia.
International journal of hematology 2005;81(1):39-44.
2004: Jan-Nicolas Machatschek; André Schrauder; Frank Helm; Martin Schrappe; Alexander Claviez
Acute lymphoblastic leukemia and Klinefelter syndrome in children: two cases and review of the literature.
Pediatric hematology and oncology 2004;21(7):621-6.
2003: Lorenz Grigull; R Beier; André Schrauder; Philip Kirschner; L Loening; T Jack; Karl Welte; Karl-Walter Sykora; Martin Schrappe
Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL.
Mycoses 2003;46(11-12):441-6.
2002: Lorenz Grigull; André Schrauder; A Schmitt-Thomssen; K Sykora; K Welte
Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection.
Infection 2002;30(5):267-71.
2002: Lothar Hambach; Matthias Eder; Elke Dammann; André Schrauder; Karl-Walter Sykora; Christian Dieterich; Philip Kirschner; Jürgen Novotny; Arnold Ganser; Bernd Hertenstein
Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation.
Haematologica 2002;87(6):643-51.